Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-12-05

FDA Approved: BENZAMYCIN — Supplemental Application (Bausch Health US, LLC)

View source ↗

Summary

The FDA approved a supplemental application for Benzamycin (erythromycin and benzoyl peroxide) by Bausch Health US, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BENZAMYCIN (erythromycin and benzoyl peroxide)

Snippet

SUPPL AP for BENZAMYCIN (ERYTHROMYCIN AND BENZOYL PEROXIDE)